Companies / Foghorn Therapeutics Inc.

Foghorn Therapeutics Inc.

Nasdaq: FHTXCIK 1822462CAMBRIDGE, MA

Financials · FY2025

Revenue$30.91M
Net income$-74.28M
Total debt$0
Cash$68.08M
Diluted EPS$-1.18
Shares outstanding59.4M

Ownership

59.4M shares outstanding · as of Jul 31, 2026
73.3%Institutions
Ownership
Institutions73.34%43,551,911
Public float26.66%15,833,404

% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.

Insiders 20

View all →
Insider% of sharesShares
Afeyan NoubarFormerDirector · 10% owner
——
Bellon Steven F.Chief Scientific Officer
——
Cardama Alfonso QuintasFormerChief Medical Officer
——
Costa CarlosFormerChief People Officer
——
Flagship Pioneering Fund VII General Partner LLCFormerDirector · 10% owner
——
Flagship Pioneering Fund VII, L.P.FormerDirector · 10% owner
——
Flagship Pioneering Fund VI, L.P.FormerDirector · 10% owner
——
Flagship Pioneering Special Opportunities Fund II General Partner LLCFormerDirector · 10% owner
——
Flagship Pioneering Special Opportunities Fund II, L.P.FormerDirector · 10% owner
——
Flagship Ventures Fund V General Partner LLCFormerDirector · 10% owner
——

Institutional holders 97

View all →
HolderValue% of shares
Flagship Pioneering Fund VI, L.P.$60.58M21.34%
Fmr LLC$29.14M9.09%
Bvf INC/IL$27.92M9.84%
Deerfield Management Company, L.P.$21.01M7.40%
Raymond James Financial Inc$13.53M4.22%
BlackRock, Inc.$12.82M4.42%
Vanguard Group Inc$10.42M3.25%
Euclidean Capital LLC$8.50M2.65%
Geode Capital Management, LLC$4.06M1.43%
Siren, L.L.C.$3.89M1.21%

Activity

View all →
InsidersInstitutions
What insiders are doing in this stock (Form 4).
DateActorActionSecurityValueShares ΔPosition afterImpact
Jun 24, 2026Smith Ian F
Director
GrantStock Options (Right to buy)—+28K
28,000
0.05% of shares
low
Jun 24, 2026Gill Simba
Director
GrantStock Options (Right to buy)—+28K
28,000
0.05% of shares
low
Jun 24, 2026Parshall B Lynne
Director
GrantStock Options (Right to buy)—+28K
28,000
0.05% of shares
low
Jan 30, 2026LaCascia Michael
Executive
GrantStock option (right to buy)—+295K
295,000
0.50% of shares
low
Jan 30, 2026Bellon Steven F.
Executive
GrantStock Option (right to buy)—+300K
300,000
0.51% of shares
low
Feb 5, 2026Gottschalk Adrian
CEO
GrantStock option (right to buy)—+1.1M
1,075,000
1.81% of shares
low
Jan 13, 2026Flagship Pioneering Fund VI, L.P.
Director
GrantSeries 2 Warrants to purchase Common Stock—+1.1M
1,117,734
1.88% of shares
low
Jan 13, 2026Flagship Pioneering Fund VI, L.P.
Director
GrantSeries 1 Warrants to purchase Common Stock—+1.1M
1,117,734
1.88% of shares
low

5%+ ownership events

Schedule 13D / 13G
FilerStance% of classSharesDate
Deerfield Mgmt, L.P.Passive13G/A———

Securities

via CUSIP / OpenFIGI
SymbolTypeMarketCUSIPFIGI
FHTX——344174107—